Pomegranate Cloud Doctor (POM.US) IPO priced at 4-6 USD per ADS, intending to raise 25 million USD.
Chinese online medical platform Pomegranate Cloud Doctor (PomDoctor) announced the IPO pricing terms on Tuesday.
Chinese online medical platform PomDoctor announced the IPO pricing terms on Tuesday. The company, based in Guangzhou, China, plans to issue 5 million American Depositary Shares (ADS) at a price of $4 to $6, raising $25 million. Based on the midpoint of the proposed price range, PomDoctor's market value will reach $592 million.
PomDoctor is a Chinese online medical service platform for chronic diseases. As of December 31, 2024, the company has accumulated over 212,800 contracted doctors, issued over 3 million prescriptions, and served 699,000 patients.
Founded in 2010, PomDoctor generated revenue of $48 million in the 12 months leading up to December 31, 2024. The company plans to list on the Nasdaq under the stock symbol "POM". Joseph Stone Capital and Uphorizon are the joint lead underwriters for the transaction.
RECOMMEND

For the Third Consecutive Month, China Reduces U.S. Treasury Holdings by $900 Million in May, While Japan and the United Kingdom Increase Holdings
18/07/2025

Tariff-Driven Inflation Arrives with Delay as U.S. Consumers Begin to Feel the Initial Pinch
18/07/2025

Multiple Countries in High-Stakes Talks with the U.S.; EU Considers Invoking “Anti-Coercion Tool” as U.S. Plans Unified Tariffs on 150 Nations
18/07/2025